Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MED12 overexpression is a frequent event in castration-resistant prostate cancer.
Adler D, Offermann A, Braun M, Menon R, Syring I, Nowak M, Halbach R, Vogel W, Ruiz C, Zellweger T, Rentsch CA, Svensson M, Andren O, Bubendorf L, Biskup S, Duensing S, Kirfel J, Perner S. Adler D, et al. Among authors: bubendorf l. Endocr Relat Cancer. 2014 Aug;21(4):663-675. doi: 10.1530/ERC-14-0171. Epub 2014 Jun 17. Endocr Relat Cancer. 2014. PMID: 24938407
Expression patterns of potential therapeutic targets in prostate cancer.
Zellweger T, Ninck C, Bloch M, Mirlacher M, Koivisto PA, Helin HJ, Mihatsch MJ, Gasser TC, Bubendorf L. Zellweger T, et al. Among authors: bubendorf l. Int J Cancer. 2005 Feb 10;113(4):619-28. doi: 10.1002/ijc.20615. Int J Cancer. 2005. PMID: 15472903 Free article.
Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Goffin V, Nevalainen MT. Dagvadorj A, et al. Among authors: bubendorf l. Endocrinology. 2007 Jul;148(7):3089-101. doi: 10.1210/en.2006-1761. Epub 2007 Apr 5. Endocrinology. 2007. PMID: 17412813 Free article.
Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
Tan SH, Dagvadorj A, Shen F, Gu L, Liao Z, Abdulghani J, Zhang Y, Gelmann EP, Zellweger T, Culig Z, Visakorpi T, Bubendorf L, Kirken RA, Karras J, Nevalainen MT. Tan SH, et al. Among authors: bubendorf l. Cancer Res. 2008 Jan 1;68(1):236-48. doi: 10.1158/0008-5472.CAN-07-2972. Cancer Res. 2008. PMID: 18172316
Stat3 promotes metastatic progression of prostate cancer.
Abdulghani J, Gu L, Dagvadorj A, Lutz J, Leiby B, Bonuccelli G, Lisanti MP, Zellweger T, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Nevalainen MT. Abdulghani J, et al. Among authors: bubendorf l. Am J Pathol. 2008 Jun;172(6):1717-28. doi: 10.2353/ajpath.2008.071054. Epub 2008 May 15. Am J Pathol. 2008. PMID: 18483213 Free PMC article.
ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor.
Scheble VJ, Braun M, Beroukhim R, Mermel CH, Ruiz C, Wilbertz T, Stiedl AC, Petersen K, Reischl M, Kuefer R, Schilling D, Fend F, Kristiansen G, Meyerson M, Rubin MA, Bubendorf L, Perner S. Scheble VJ, et al. Among authors: bubendorf l. Mod Pathol. 2010 Aug;23(8):1061-7. doi: 10.1038/modpathol.2010.87. Epub 2010 May 14. Mod Pathol. 2010. PMID: 20473283 Free PMC article.
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.
Ruiz C, Oeggerli M, Germann M, Gluderer S, Stocker H, Andreozzi M, Thalmann GN, Cecchini MG, Zellweger T, Stürm S, Koivisto PA, Helin HJ, Gelmann EP, Glass AG, Gasser TC, Terracciano LM, Bachmann A, Wyler S, Bubendorf L, Rentsch CA. Ruiz C, et al. Among authors: bubendorf l. Prostate. 2012 Nov;72(15):1678-87. doi: 10.1002/pros.22521. Epub 2012 Apr 2. Prostate. 2012. PMID: 22473923
347 results